(Q24197676)

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Controlled trial of azathioprine in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Place of azathioprine for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

The clinical pharmacology of 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

6-Mercaptopurine Therapy in Selected Cases of Corticosteroid-Dependent Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Clinical pharmacology and pharmacogenetics of thiopurines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Azathioprine in the treatment of children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Azathioprine for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Further experience with azathioprine for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Azathioprine: an adjunct to surgical therapy of granulomatous enteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Dangers of immunosuppressive drugs in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

A dose-ranging study of azathioprine pharmacokinetics after single-dose administration of a delayed-release oral formulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Long-term immunosuppressive treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000545.PUB4

7 January 2021

10.1002/14651858.CD000545.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23633304

1 reference

Consolidated OpenCitations Corpus – April 2017